COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 325: Articles 3241-3250  | Next

Impact of Adjustment for Differential Testing by Age and Sex on Apparent Epidemiology of SARS-CoV-2 Infection in Ontario, Canada
Bosco, S., Peng, A., Simmons, A. E., Tuite, A., Fisman, D.
10.1101/2023.08.01.23293449 — Posted: 2023-08-06
COVID-19 among migrants, refugees, and internally displaced persons: systematic review, meta-analysis and qualitative synthesis of the global empirical literature
Hintermeier, M., Gottlieb, N. D., Rohleder, S., Oppenberg, J., Baroudi, M., Pernitez-Agan, S., Lopez, J., Flores, S., Mohsenpour, A. M., Wickramage, K., Bozorgmehr, K.
10.1101/2023.08.03.23293586 — Posted: 2023-08-06
Work Attendance during Acute Respiratory Illness Before and During the COVID-19 Pandemic, United States, 2018-2022
Ahmed, F., Nowalk, M. P., Zimmerman, R., Bear, T., Grijalva, C. G., Talbot, H. K., Florea, A., Tartof, S., Gaglani, M., Smith, M. E., McLean, H. Q., King, J., Martin, E. T., Monto, A., Phillips, H., Wernli, K. J., Flannery, B., Chung, J., Uzicanin, A.
10.1101/2023.08.03.23293611 — Posted: 2023-08-06
The post-COVID-19 population has a high prevalence of crossreactive antibodies to spikes from all Orthocoronavirinae genera
Singh, G., Abbad, A., Kleiner, G., Srivastava, K., Gleason, C., Carreno Quiroz, J. M., Simon, V., Krammer, F.
10.1101/2023.08.01.23293522 — Posted: 2023-08-06
OUTCOME OF COVID-19 PATIENTS ON STEROID THERAPY: A LONGITUDINAL STUDY
Kataria, A., Bahurupi, Y., Chikara, G., Panda, P.
10.1101/2023.08.03.23293425 — Posted: 2023-08-06
COVID pandemic impact on hypertension management in North-East London: an observational cohort study using electronic health records
Rison, S. C., Redfern, O., Mathur, R., Dostal, I., Carvalho, C., Raisi-Estabragh, Z. R., Robson, J. P.
10.1101/2023.08.02.23293505 — Posted: 2023-08-06
Fit notes associated with COVID-19 in 24 million patients' primary care records: A cohort study in OpenSAFELY-TPP
The OpenSAFELY Collaborative, , Schaffer, A. L., Park, R. Y., Tazare, J., Bhaskaran, K., MacKenna, B., Denaxas, S., Dillingham, I., Bacon, S. C., Mehrkar, A., Bates, C., Goldacre, B., Greaves, F., Macleod, J., Tomlinson, L., Walker, A. J., National Core Studies Collaborative
10.1101/2023.07.28.23293269 — Posted: 2023-08-05
CLINICAL AND SEROLOGICAL PREDICTORS OF POST COVID-19 CONDITION: FINDINGS FROM A CANADIAN PROSPECTIVE COHORT STUDY
Collins, E., Galipeau, Y., Arnold, C., Bhereur, A., Booth, R., Buchan, C. A., Cooper, C., Crawley, A. M., Mccluskie, P., McGuinty, M., Pelchat, M., Rocheleau, L., Saginur, R., Gravel, C., Hawken, S., Langlois, M.-A., Little, J.
10.1101/2023.07.29.23293334 — Posted: 2023-08-05
Systematic Review and Meta-Analysis Protocol of the Efficacy and Safety of COVID-19 Drug Candidates Targeting Host Enzymes Involved in Immune Response
Mushebenge, A. G.-A., Ugbaja, S. C., Mbatha, N. A., Riziki, M. G., Muzumbukilwa, T. W., Kadima, M. G., Kumalo, H. M.
10.1101/2023.07.28.23293338 — Posted: 2023-08-05
Healthcare resource utilization and costs associated with COVID-19 among pediatrics managed in the community or hospital setting in England: a population-based cohort study
Yang, J., Andersen, K. M., Rai, K. K., Tritton, T., Mugwagwa, T., Tsang, C., Reimbaeva, M., McGrath, L., Payne, P., Backhouse, B. E., Mendes, D., Butfield, R., Wood, R., Nguyen, J. L.
10.1101/2023.07.28.23293335 — Posted: 2023-08-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).